menu search

ALLR / Allarity's stock falls after saying enrollment in two clinical trials is slow

Allarity's stock falls after saying enrollment in two clinical trials is slow
Shares of Allarity Therapeutics Inc. ALLR, -4.51% plunged 17% in premarket trading on Tuesday after the company told investors that it's struggled to enroll enough patients in Phase 2 studies for Ixempra and senoparib, citing the impact of the pandemic on staffing for clinical-trial sites. The company is testing Ixempra as a treatment for metastatic breast cancer and stenoparib for ovarian cancer. Read More
Posted: Mar 28 2023, 08:34
Author Name: Market Watch
Views: 110579

ALLR News  

Top 5 Health Care Stocks That Could Blast Off In August - Biolase (NASDAQ:BIOL), Allarity Therapeutics (NASDAQ:ALLR)

By Benzinga
August 4, 2023

Top 5 Health Care Stocks That Could Blast Off In August - Biolase (NASDAQ:BIOL), Allarity Therapeutics (NASDAQ:ALLR)

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. more_horizontal

Why Is Allarity Therapeutics (ALLR) Stock Up 30% Today?

By InvestorPlace
July 5, 2023

Why Is Allarity Therapeutics (ALLR) Stock Up 30% Today?

Shares of clinical-stage precision medicine company Allarity Therapeutics (NASDAQ: ALLR ) initially soared to a 60% gain for the midweek session befor more_horizontal

Why Is Allarity Therapeutics (ALLR) Stock Down 22% Today?

By InvestorPlace
April 19, 2023

Why Is Allarity Therapeutics (ALLR) Stock Down 22% Today?

Allarity Therapeutics (NASDAQ: ALLR ) stock is falling hard on Wednesday after the clinical-stage pharmaceutical company launched a public offering. T more_horizontal

7 Sorry Pharma Stocks to Sell in April Before It's Too Late

By InvestorPlace
April 16, 2023

7 Sorry Pharma Stocks to Sell in April Before It's Too Late

Finding the best pharma stocks to sell can be an all-or-nothing kind of business. If you score on a company making a breakthrough in a new drug or tre more_horizontal

Allarity's stock falls after saying enrollment in two clinical trials is slow

By Market Watch
March 28, 2023

Allarity's stock falls after saying enrollment in two clinical trials is slow

Shares of Allarity Therapeutics Inc. ALLR, -4.51% plunged 17% in premarket trading on Tuesday after the company told investors that it's struggled to more_horizontal

Allarity Therapeutics: 1:35 Reverse Stock Split Goes Into Effect

By Pulse2
March 25, 2023

Allarity Therapeutics: 1:35 Reverse Stock Split Goes Into Effect

Allarity Therapeutics announced that it intends to effect a reverse stock split of its common stock, at a ratio of 1 post-split share for every 35 pre more_horizontal

Why Is Allarity Therapeutics (ALLR) Stock Down 23% Today?

By InvestorPlace
March 24, 2023

Why Is Allarity Therapeutics (ALLR) Stock Down 23% Today?

Allarity Therapeutics (NASDAQ: ALLR ) stock is sliding lower on Friday after announcing a reverse stock split. According to a press release, the comp more_horizontal


Search within

Pages Search Results: